13667811000001109: Tyverb 250mg tablets (GlaxoSmithKline) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Tyverb 250mg tablets (GlaxoSmithKline)
\UK product\Virtual medicinal product\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)
\UK product\Virtual therapeutic moiety\Lapatinib\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)
\UK product\Trade family\Tyverb\Tyverb 250mg tablets (GlaxoSmithKline)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing phosphotransferase inhibitor\Product containing protein kinase inhibitor\Product containing protein-tyrosine kinase inhibitor\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)
\Medicinal product\Medicinal product categorized by structure\Product containing quinazoline\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product)\Product containing lapatinib\Lapatinib\Lapatinib 250mg tablets\Tyverb 250mg tablets (GlaxoSmithKline)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

48687801000001110 Tyverb 250mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

92772401000001113 Tyverb 250mg tablets (Novartis Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tyverb 250mg tablets (GlaxoSmithKline)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	Lapatinib 250mg tablets	false	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	Lapatinib 250mg tablets	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	Product containing precisely lapatinib ditosylate 250 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has active ingredient	Lapatinib ditosylate	false	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	Tyverb	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has specific active ingredient	Lapatinib ditosylate monohydrate	false	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has specific active ingredient	Lapatinib ditosylate monohydrate	true	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Lapatinib	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets	Is pack of	False	Tyverb 250mg tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline) 70 tablet 7 x 10 tablets	Has AMP	True	Tyverb 250mg tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 84 tablet 7 x 12 tablets	Has AMP	True	Tyverb 250mg tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier
Tyverb 250mg tablets (GlaxoSmithKline UK Ltd) 105 tablet	Has AMP	True	Tyverb 250mg tablets (GlaxoSmithKline)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
48687801000001110	Tyverb 250mg tablets (GlaxoSmithKline) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
92772401000001113	Tyverb 250mg tablets (Novartis Pharmaceuticals UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module